Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in STLN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.7M | $25.8M | +7.5% | 4.750% | 0.00% |
| 2 | DEERFIELD MANAGEMENT COMPANY, L.P. | 3.4M | $18.2M | 0.0% | 3.361% | 0.19% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $17.7M | -6.1% | 3.266% | 0.00% |
| 4 | JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 2.5M | $13.4M | 0.0% | 2.465% | 8.42% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $10.3M | +8.1% | 1.900% | 0.00% |
| 6 | CITADEL ADVISORS LLC | 1.7M | $9.4M | -26.2% | 1.738% | 0.00% |
| 7 | GOLDMAN SACHS GROUP INC | 1.7M | $9.4M | +28.4% | 1.736% | 0.00% |
| 8 | WEXFORD CAPITAL LP | 1.7M | $9.3M | 0.0% | 1.712% | 1.19% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.6M | $8.7M | +121.5% | 1.610% | 0.00% |
| 10 | STATE STREET CORP | 1.6M | $8.4M | +6.3% | 1.553% | 0.00% |
| 11 | Nuveen, LLC | 1.4M | $7.6M | +1378.8% | 1.409% | 0.00% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1.4M | $7.4M | +51.3% | 1.366% | 0.01% |
| 13 | JANE STREET GROUP, LLC | 1.4M | $7.3M | +114.8% | 1.351% | 0.00% |
| 14 | CenterBook Partners LP | 1.2M | $6.7M | -20.8% | 1.242% | 0.33% |
| 15 | MARSHALL WACE, LLP | 1.2M | $6.6M | +257.2% | 1.223% | 0.01% |
| 16 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.0M | $5.5M | +16.7% | 1.007% | 0.00% |
| 17 | BRC Group Holdings, Inc. | 743K | $4.0M | -20.1% | 0.743% | 0.93% |
| 18 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 711K | $3.9M | +69.5% | 0.711% | 0.00% |
| 19 | TWO SIGMA INVESTMENTS, LP | 669K | $3.6M | +117.3% | 0.669% | 0.00% |
| 20 | NORTHERN TRUST CORP | 592K | $3.2M | +5.9% | 0.592% | 0.00% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 502K | $2.7M | +3.9% | 0.502% | 0.00% |
| 22 | FourWorld Capital Management LLC | 499K | $2.7M | 0.0% | 0.499% | 2.47% |
| 23 | Manatuck Hill Partners, LLC | 450K | $2.4M | — | 0.450% | 0.81% |
| 24 | Walleye Capital LLC | 446K | $2.4M | — | 0.446% | 0.01% |
| 25 | Inspire Investing, LLC | 424K | $2.3M | — | 0.424% | 0.09% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in STLN — a direct measure of their conviction.
Filings activity in STLN during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new STLN position in Q2 2026
Institutions that fully closed their STLN position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +2.6% | 43.05% | +1.69 pp | $228M | +80% |
| Q1 2026 | 116 | 0.9% | 41.36% | +37.25 pp | $127M | 9.1% |
| Q4 2025 | 117 | +9.3% | 4.11% | +0.63 pp | $139M | +17% |
| Q3 2025 | 107 | +35% | 3.48% | +0.37 pp | $119M | +99% |
| Q2 2025 | 79 | +84% | 3.11% | +1.47 pp | $60M | +211% |
| Q1 2025 | 43 | +39% | 1.64% | +0.23 pp | $19M | +331% |
| Q4 2024 | 31 | 8.8% | 1.41% | 0.57 pp | $4M | 36% |
| Q3 2024 | 34 | — | 1.98% | — | $7M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as a key fundamental indicator because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 9, 2026 | Chernett Jorey | Buy | 20K | $3.10 | $62K |
Institutional ownership and quarterly buying activity across the largest Healthcare Providers peers.
| Ticker | Company | Market Cap | Inst. Ownership | Holders | Net Buyers − Sellers |
|---|---|---|---|---|---|
| ACH | Accendra Health, Inc. | $16M | 83.0% | 141 | -3 |
Quick answers to the most common questions about buying STLN stock.
Based on Q2 2026 13F filings, institutional ownership of Starling Oncology, Inc. stands at 43.0%, held across 119 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of STLN, with approximately 4,749,030 shares worth $0.03B as of Q2 2026.
Yes — 5 widely-followed marquee investors appear among the top 25 institutional holders of STLN, including CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for STLN is 78 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
26 institutions opened new positions in STLN during Q2 2026, while 22 fully exited. 85 added to existing positions and 8 trimmed.
STLN institutional ownership rose by 1.69 percentage points quarter-over-quarter, with a net change of +3 holders.
The top 10 institutions account for 57.3% of all reported 13F value in STLN, and the top 25 account for 87.4%.
Across the largest Healthcare Providers peers, institutional ownership levels are: ACH (83.0%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.